These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8718561

  • 1. Effects of slowly performed daytime hemodialysis (slow HD) on the pharmacokinetics of vancomycin in hemodynamically unstable patients with renal failure.
    Kihara M, Ikeda Y, Fujita H, Tamura K, Yabana M, Takagi N, Umemura S, Ishii M.
    Blood Purif; 1996; 14(1):20-5. PubMed ID: 8718561
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of single-dose intravenous amikacin in critically ill patients undergoing slow hemodialysis.
    Kihara M, Ikeda Y, Takagi N, Fujita H, Shibata K, Masumori S, Shiratori K, Umemura S, Shionoiri H, Ishii M.
    Intensive Care Med; 1995 Apr; 21(4):348-51. PubMed ID: 7650258
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA.
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
    Kihara M, Ikeda Y, Shibata K, Masumori S, Ebira H, Shiratori K, Ueda S, Takagi N, Umemura S, Shionoiri H.
    Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939
    [Abstract] [Full Text] [Related]

  • 5. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F, Uehlinger DE.
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [Abstract] [Full Text] [Related]

  • 6. Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease.
    Touchette MA, Patel RV, Anandan JV, Dumler F, Zarowitz BJ.
    Am J Kidney Dis; 1995 Sep; 26(3):469-74. PubMed ID: 7645555
    [Abstract] [Full Text] [Related]

  • 7. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME, Lipman J, Tett SE.
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced clearance of vancomycin by hemodialysis in a child.
    Schoumacher R, Chevalier RL, Gomez RA, Rogol AD, Cummings R, Spyker DA.
    Pediatr Nephrol; 1989 Jan; 3(1):83-5. PubMed ID: 2702093
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
    Kielstein JT, Czock D, Schöpke T, Hafer C, Bode-Böger SM, Kuse E, Keller F, Fliser D.
    Crit Care Med; 2006 Jan; 34(1):51-6. PubMed ID: 16374156
    [Abstract] [Full Text] [Related]

  • 11. Slow hemodialysis performed during the day in managing renal failure in critically ill patients.
    Kihara M, Ikeda Y, Shibata K, Masumori S, Fujita H, Ebira H, Toya Y, Takagi N, Shionoiri H, Umemura S.
    Nephron; 1994 Jan; 67(1):36-41. PubMed ID: 8052365
    [Abstract] [Full Text] [Related]

  • 12. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA.
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [Abstract] [Full Text] [Related]

  • 13. Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis.
    Wolter K, Claus M, Wagner K, Fritschka E.
    Clin Nephrol; 1994 Dec; 42(6):389-97. PubMed ID: 7882603
    [Abstract] [Full Text] [Related]

  • 14. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N, Ratanajamit C, Kasiwong S, Wangsiripaisan A.
    J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
    [Abstract] [Full Text] [Related]

  • 15. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA, Neudeck BL, Welage LS, Patel JA, Swartz RD.
    Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetics of vancomycin in continuous veno-venous hemofiltration].
    Gu Q, Zhu ZH, Ge M, Ge WH.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):114-6. PubMed ID: 12857476
    [Abstract] [Full Text] [Related]

  • 17. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation.
    Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Picetti E, Manini P, Andreoli R, Cabassi A.
    Nephrol Dial Transplant; 2006 May; 21(5):1402-6. PubMed ID: 16504979
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR, Humphreys MH, Gambertoglio JG, Schoenfeld P, Cundy KC, Aweeka FT.
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J, Cao C, Rivas MC, Cano M, Fernandez E, Montoliu J.
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
    De Bock V, Verbeelen D, Maes V, Sennesael J.
    Nephrol Dial Transplant; 1989 Jul; 4(7):635-9. PubMed ID: 2510061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.